SCHEMBL13619043

SCHEMBL13619043

O=c1[nH]ccnc1-c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.47
PDE3A Q14432 1/20 0.47
KDM4E B2RXH2 2/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
CYP19A1 P11511 1/20 0.41
IDO1 P14902 1/20 0.40
TDO2 P48775 1/20 0.40
ALDH1A1 P00352 2/20 0.39
FFAR2 O15552 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
MAP4K4 O95819 1/20 0.37
NAMPT P43490 1/20 0.37
HTR2B P41595 1/20 0.37
PDGFRB P09619 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13619228 0.81 NISCH (0.56) KDM4ERAB9ANPC1ALDH1A1GAA
SCHEMBL5065601 0.81 PDE3B (0.47) PDE3BPDE3AKDM4ERAB9ANPC1
SCHEMBL29948010 0.81 PDE3B (0.47) PDE3BPDE3AKDM4EALDH1A1PDGFRB
SCHEMBL17151506 0.81 PDE3B (0.47) PDE3BPDE3ARAB9ANAMPTHTR2B
SCHEMBL5065569 0.81 MTOR (0.53) PDE3BPDE3AKDM4ERAB9ANPC1
SCHEMBL15144399 0.77 PDE3B (0.51) PDE3BPDE3AKDM4ERAB9ANPC1
SCHEMBL6619540 0.73 DAO (0.42) PDE3BPDE3AKDM4ERAB9ANPC1
SCHEMBL4691850 0.73 PDE3B (0.47) PDE3BPDE3AKDM4ERAB9ANPC1
SCHEMBL482165 0.72 NISCH (0.64) PDE3BPDE3AKDM4ERAB9ANPC1
SCHEMBL30719409 0.72 AURKA (0.40) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268624-B1 ARYLPYRAZINONE DERIVATIVES INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2013-07-31 EP disclosed
WO-2009132739-A1 ARYLPYRAZINONE DERIVATIVES INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2009-11-05 WO disclosed